Risk factors

Kyntra Bio (KYNB) risk factors

Item 1A of every Kyntra Bio, Inc. 10-K on file, and what changed from one year to the next.

Open KYNB in Gloomberb →
  • FY2025 10-K risk factors

    76 risks, 6 new, 22 dropped, 16 reworded since the prior year. Kyntra Bio highlights risks from single-source roxadustat API suppliers in China and reliance on partners like Astellas and Fortis.

    Filed Mar 16, 2026
  • FY2024 10-K risk factors

    92 risks. Roxadustat and FG-3246 drive our business value and commercial success. Drug development faces extensive regulatory review and intense competition globally. Third-party manufacturers and collaborators are critical to our supply chain and clinical success.

    Filed Mar 17, 2025